Cargando…

Dynamic changes of CSF clusterin levels across the Alzheimer’s disease continuum

BACKGROUND: Clusterin is a multifunctional protein, which is associated with the pathogenesis and the development of Alzheimer’s disease (AD). Compared with normal controls, inconsistent results have yielded in previous studies for concentration of cerebrospinal fluid (CSF) clusterin in AD patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Lian, Wang, Zhi-Bo, Ma, Ling-Zhi, Cao, Xi-Peng, Tan, Lan, Tan, Meng-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801612/ https://www.ncbi.nlm.nih.gov/pubmed/36581903 http://dx.doi.org/10.1186/s12883-022-03038-w

Ejemplares similares

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
por: Wang, Jun, et al.
Publicado: (2020)

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum
por: Paciotti, Silvia, et al.
Publicado: (2023)

The dynamics of plasma biomarkers across the Alzheimer’s continuum
por: Guo, Yu, et al.
Publicado: (2023)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study
por: Ma, Ling-Zhi, et al.
Publicado: (2020)

Clusterin transduces Alzheimer-risk signals to amyloidogenesis
por: Liu, Xi, et al.
Publicado: (2022)

Plasma clusterin levels and risk of dementia, Alzheimer's disease, and stroke
por: Weinstein, Galit, et al.
Publicado: (2016)

Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
por: Ling, I-Fang, et al.
Publicado: (2012)

No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
por: Silajdžić, Edina, et al.
Publicado: (2012)

Dynamic modeling of practice effects across the healthy aging-Alzheimer’s disease continuum
por: Bender, Andrew R., et al.
Publicado: (2022)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
por: Milinkeviciute, Giedre, et al.
Publicado: (2023)

Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
por: Salvadó, Gemma, et al.
Publicado: (2022)

Clusterin induced by N,N′-Dinitrosopiperazine is involved in nasopharyngeal carcinoma metastasis
por: Li, Yuejin, et al.
Publicado: (2015)

Alzheimer's risk variants in the clusterin gene are associated with alternative splicing
por: Szymanski, M, et al.
Publicado: (2011)

Disrupted global metastability and static and dynamic brain connectivity across individuals in the Alzheimer’s disease continuum
por: Córdova-Palomera, Aldo, et al.
Publicado: (2017)

Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015)

Development of a Label-Free Immunosensor for Clusterin Detection as an Alzheimer’s Biomarker
por: Islam, Kamrul, et al.
Publicado: (2018)

Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
por: Foster, Evangeline M., et al.
Publicado: (2019)

Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
por: Bradley, David
Publicado: (2020)

Graphene FET Sensors for Alzheimer’s Disease Protein Biomarker Clusterin Detection
por: Bungon, Theodore, et al.
Publicado: (2021)

Correction to: Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort
por: Liu, Yi, et al.
Publicado: (2022)

Subjective cognitive decline: opposite links to neurodegeneration across the Alzheimer’s continuum
por: Kuhn, Elizabeth, et al.
Publicado: (2021)

Technical Review of Clinical Outcomes Assessments Across the Continuum of Alzheimer's Disease
por: DiBenedetti, Dana B., et al.
Publicado: (2023)

Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy
por: Dombai, Brigitta, et al.
Publicado: (2017)

The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum
por: Xu, Wei, et al.
Publicado: (2016)

Alterations of CSF Cystatin C Levels and Their Correlations with CSF Αβ40 and Αβ42 Levels in Patients with Alzheimer's Disease, Dementia with Lewy Bodies and the Atrophic Form of General Paresis
por: Zhong, Xiao-Mei, et al.
Publicado: (2013)

Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum
por: Tosun, Duygu, et al.
Publicado: (2021)

The clinical significance of plasma clusterin and Aβ in the longitudinal follow-up of patients with Alzheimer’s disease
por: Hsu, Jung-Lung, et al.
Publicado: (2017)

Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer’s Disease
por: Chen, Ping, et al.
Publicado: (2013)

Clusterin accumulates in synapses in Alzheimer’s disease and is increased in apolipoprotein E4 carriers
por: Jackson, Rosemary J, et al.
Publicado: (2019)

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2
por: Gispert, Juan Domingo, et al.
Publicado: (2016)

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
por: Benedet, Andréa L., et al.
Publicado: (2021)

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
por: Goossens, Julie, et al.
Publicado: (2023)

Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition
por: Dicks, Ellen, et al.
Publicado: (2020)

Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
por: Pelkmans, Wiesje, et al.
Publicado: (2021)

Network‐wise concordance of multimodal neuroimaging features across the Alzheimer's disease continuum
por: Stocks, Jane, et al.
Publicado: (2022)

Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum
por: Toledo, Jon B., et al.
Publicado: (2022)

Common Variants in PLXNA4 and Correlation to CSF-related Phenotypes in Alzheimer's Disease
por: Han, Qiu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bobabaldrpagocsv3pt01mhjmb